ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,205Medicare Part D Prescriptions Filled, Including Refills

Rank: 169 out of 1185

$1.02M Total Retail Price of All Prescriptions

Rank: 37 out of 1185

178 Patients Receiving at Least One Drug in Part D
15%Patients 65 Years and Older
99% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 1,855 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$91 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

63 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
DIVALPROEX SODIUM ER 556 56 1 158
LEVOTHYROXINE SODIUM 475 91 2 3
RISPERIDONE 441 50 3 72
RANITIDINE HCL 383 69 4 17
FENOFIBRATE 314 60 5 55
CARBAMAZEPINE 307 74 6 183
OLANZAPINE 241 37 7 156
SIMVASTATIN 236 62 8 5
OMEPRAZOLE 236 38 8 6
QUETIAPINE FUMARATE 232 58 10 93
DIVALPROEX SODIUM 203 0 11 96
SEROQUEL 194 30 12 159
PROMETHAZINE HCL 189 13 R 13 76
BACLOFEN 174 37 14 150
BENZTROPINE MESYLATE 168 13 R 15 180
ATORVASTATIN CALCIUM 166 25 16 11
AMITIZA 164 39 17 218
LAMOTRIGINE 162 24 18 214
LITHIUM CARBONATE 162 24 18 272
ABILIFY 149 0 20 192
FUROSEMIDE 147 76 21 8
VALPROIC ACID 145 13 22 213
TAMSULOSIN HCL 145 97 22 34
CLONIDINE HCL 133 0 24 47
ZYPREXA 128 12 25 308
AMLODIPINE BESYLATE 109 14 26 1
CLOZAPINE 105 0 27 286
CARBAMAZEPINE XR 103 12 28 334
METFORMIN HCL 95 0 29 9
POLYETHYLENE GLYCOL 3350 94 0 30 60
TOPIRAMATE 94 0 30 151
NEXIUM 89 39 32 19
FLUTICASONE PROPIONATE 88 0 33 29
LISINOPRIL 86 50 34 4
PROPRANOLOL HCL 83 0 35 163
HYDROCHLOROTHIAZIDE 80 0 36 12
KLOR-CON M20 79 13 37 59
LEVETIRACETAM 79 0 37 131
LACTULOSE 70 0 39 177
FLUVOXAMINE MALEATE 69 34 40 309
LIPITOR 69 0 40 89
SINGULAIR 69 22 40 106
OXCARBAZEPINE 68 0 43 288
ERYTHROMYCIN 67 0 44 355
IBUPROFEN 65 0 45 102
NIASPAN 64 0 46 121
TEGRETOL XR 62 13 47 363
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 11 48 91
METOCLOPRAMIDE HCL 59 22 49 134
FINASTERIDE 58 12 50 132
METOPROLOL TARTRATE 56 26 51 10
CLOMIPRAMINE HCL 55 0 R 52 384
PRIMIDONE 54 0 53 322
THIORIDAZINE HCL 54 0 R 53 285
MEDROXYPROGESTERONE ACETATE 52 0 55 392
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 9, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.